Jan 20, 2021 / 07:00PM GMT
Kevin Davies -
Hello, everyone. And welcome to the first GEN Live of 2021 on a very auspicious day Inauguration Day for the new administration. So thank you very much for joining us and tearing ourself away from the screen where we've been watching history being made.
I'm Kevin Davies, Editor-at-Large with GEN, Genetic Engineering & Biotechnology News, Executive Editor of The CRISPR Journal and the author of a new book, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing.
I'm joined by 3 of my colleagues, who most of you will have met before, Julianna LeMieux -- Dr. Julianna LeMieux, Alex Philippidis and John Sterling, all editorial colleagues with GEN; and 4 very distinguished guests, who I'll introduce in just a couple of minutes.
The title of today's episode is GEN 40: Looking Back and Thinking Ahead. GEN celebrates its 40th anniversary this year. The magazine has literally written and told the biotech story for the past 4 decades. With COVID-19 vaccines paving the way CRISPR's Nobel Prize and dramatic advances in gene therapy, neuroscience, regenerative
Athersys Inc GEN 40: Looking Back and Thinking Ahead Call Transcript
Feb 12, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers